SAHARA trial demonstrates sustained TearCare benefits for evaporative DED ByAbigail LewisAugust 7th 2025New findings confirm TearCare's long-term effectiveness for dry eye disease, showing significant patient improvements with minimal treatments over 2 years.
Viridian partners with Kissei Pharmaceutical to develop thyroid eye disease therapies in JapanByAbigail LewisAugust 7th 2025